Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 17 stocks, with a combined market cap of $2,612.83 billion, total revenue of $615.94 billion and a weighted average PE ratio of 22.48.

Market Cap
2,612.83B
Revenue
615.94B
Profits
116.22B
PE Ratio
22.48
Profit Margin
18.87%
Dividend Yield
2.26%

17 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company555.99B
-0.50%
291,82532.07B
2JNJJohnson & Johnson382.47B
-0.17%
1,163,48095.33B
3MRKMerck & Co., Inc.262.17B
-0.51%
1,212,05559.31B
4ABBVAbbVie Inc.256.50B
-0.73%
364,82255.14B
5NVSNovartis AG202.86B
-1.91%
271,33052.32B
6AZNAstraZeneca PLC200.96B
-1.57%
663,15945.00B
7PFEPfizer Inc.167.25B
0.68%
7,842,19768.54B
8AMGNAmgen Inc.145.86B
-1.18%
152,37526.83B
9SNYSanofi118.61B
-0.83%
203,89450.70B
10BMYBristol-Myers Squibb Company101.70B
-0.01%
1,267,46344.94B
11GILDGilead Sciences, Inc.97.61B
-0.10%
608,87627.39B
12GSKGSK plc75.44B
-1.23%
313,16135.73B
13BIIBBiogen Inc.33.74B
-1.19%
74,0899.99B
14GRFSGrifols, S.A.8.55B
0.98%
188,4506.45B
15OGNOrganon & Co.2.94B
-2.32%
484,1886.15B
16SCLXScilex Holding Company129.43M
-8.46%
285,60745.20M
17MIRAMIRA Pharmaceuticals, Inc.53.21M
-8.75%
45,364-